Trial Condition(s):

Bronchiectasis

Treatment Patterns and Economic Burden of NCFB

Bayer Identifier:

18449

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

This observational database study used healthcare claims to understand costs and treatment pattern patients with non-cystic fibrosis bronchiectasis (NCFB) in the USA. Additionally, it looked at treatment patterns in this patient population to better understand how physicians respond in terms of treatment choices to an exacerbation.

Inclusion Criteria
- Adult NCFB patients with one claim for exacerbation during the enrollment period
Exclusion Criteria
- Patients with one primary or two secondary claims for COPD during the study period
- Patients with any claims for cystic fibrosis or congential brochiectasis during the study period

Trial Summary

Enrollment Goal
5847
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Ciprofloxacin DPI (BAYQ3939)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many locations, United States

Status
Completed
 

Trial Design